A Perspective on New Zealand's Medicines Regulatory Environment

ISSN： 1364-9027

Source： International Journal of Pharmaceutical Medicine, Vol.17, Iss.1, 2003-01, pp. : 17-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The New European Regulation on Pediatric Medicines: Regulatory Perspective

By Hawcutt Daniel B. Smyth Rosalind L.

Pediatric Drugs, Vol. 10, Iss. 3, 2008-01 ,pp. : 143-146

Adis International

Access to resources Recommend Favorite

Activities to promote quality use of medicines in New Zealand

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 472, 2005-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

New Zealand Pharmacists and Pharmacist‐Only Medicines

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 34, Iss. 4, 2004-12 ,pp. : 282-284

John Wiley & Sons Inc

Access to resources Recommend Favorite

Processes for the Assessment and Introduction of New Medicines in New Zealand Hospitals

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 34, Iss. 4, 2004-12 ,pp. : 267-271

John Wiley & Sons Inc

Access to resources Recommend Favorite

Academic clinical research in the new regulatory environment

By Gennery Brian

Clinical Medicine, Vol. 5, Iss. 1, 2005-01 ,pp. : 39-41

Royal College Of Physicians

Access to resources Recommend Favorite